The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.
All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.
Board of Directors
Cynthia Verst
ACRO Chair & President Clinical Operations, IQVIA
Alistair Macdonald
ACRO Vice Chair & CEO, Syneos Health
John Ratliff
Previous ACRO Chair & CEO, Covance Drug Development
Jamie Macdonald
Chief Executive Officer, PAREXEL
Steve Rosenberg
Senior Vice President and General Manager, Oracle Health Sciences
David Johnston
Executive Vice President of Global Clinical Development, PPD
David Herron
President and CEO, Bioclinica
Glen de Vries
President and Co-Founder, Medidata Solutions
Steve Cutler
CEO, ICON
Associate Members
Colin Shannon
President & COO, PRA Health Sciences
James Corrigan
President & CEO, ERT
Become and ACRO Member and add your voice.
ACRO Staff
Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.
Doug Peddicord
Executive Director
Karen Noonan
Vice President, Global Regulatory Policy
Matt Feldman
Director of Communications
Sophia McLeod
Government & Industry Relations Specialist
Anina Adelfio
Operations & Forum Manager